Table:
begin	end	state
1	33	signal peptide
34	257	non-cytoplasmic
258	285	transmembrane
286	291	cytoplasmic
292	311	transmembrane
312	316	non-cytoplasmic
317	338	transmembrane
339	349	cytoplasmic
350	371	transmembrane
372	398	non-cytoplasmic
399	417	transmembrane
418	443	cytoplasmic
444	465	transmembrane
466	482	non-cytoplasmic
483	507	transmembrane
508	514	cytoplasmic
515	533	transmembrane
534	550	non-cytoplasmic

Input:
>WP_011653192.1 NCBI__GCF_000009265.1:WP_011653192.1
MYRAIKIFLITVCLTFSGLVFSGFAFSGLTISSEVQAQDDIHVLIDALGVGDFPEREAAI
KALVASKDPHVSQILQQLSDGLLYVNSDGGPVLLQGGTDDEPTYSDPITGEAVADVDPDL
MTKVKINNALRGVIGAATSQLTLMSPDRSARLAAAQGLLKDADPANLDLLNTAIAAEKDA
EIKNTMEAARAVLLLKTDASVEDKKAAIGTIAARGNRDALTILTTTLETAPDDLKPAIQA
DISSINRSLALWDIVQNIWYGLSLGSVLLLAAIGLAITFGVMGVINMAHGEMVMIGAYTT
YVVQEYITSAFPELADYSLAFAVPAAFVFTGFVGLVIERAVIRYLYGRPLETLLATWGVS
LILQQAVRSIFGPTNREVRNPTWMSGVFDLGGLSITWNRLWIIVFSMVVFVALLLLLKRS
AFGLQMRAVTQNRRMASSMGIRTGWVDAFTFALGSGIAGIAGVALSQIDNVSPNLGQSYI
IDSFMVVVFGGVGNLWGTLVGALSLGVVNKFLEPFAGAVLGKILVLVLIILFIQKRPRGL
FALKGRAVEA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server